For patients using nemolizumab to treat prurigo nodularis, withdrawing medication led to a greater risk for relapse, according to a study presented at the European Academy of Dermatology and Venereology meeting.
“Prurigo nodularis is a chronic neuroimmune skin disease characterized by debilitating itch and multiple pruriginous lesions. It is one of the itchiest of all,” Franz J. Legat, MD, of the department of dermatology and venereology at Medical University of Graz, said in the presentation. “In this study, we wanted to know what happened to patients with prurigo nodularis